Diffuse follicle center lymphoma, lymph nodes mult site is a type of non-Hodgkin lymphoma characterized by the proliferation of malignant B-cells in multiple lymph node sites. This condition is clinically significant due to its potential for aggressive behavior and varied treatment responses. Accurate coding with ICD-10 Code C82.58 is essential for precise diagnosis, effective documentation, appropriate medical billing, and comprehensive public health reporting.
ICD-10 Code C82.58 represents Diffuse follicle center lymphoma affecting multiple lymph node sites. This condition involves the uncontrolled growth of B-lymphocytes, leading to lymphadenopathy and potential systemic symptoms. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Diffuse follicle center lymphoma, lymph nodes mult site is a hematological malignancy that arises from the transformation of germinal center B-cells. It typically presents with lymphadenopathy and may progress to involve extranodal sites. Prompt medical attention is crucial due to its potential for aggressive progression and treatment challenges.
ICD-10 Code C82.58 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, facilitating accurate tracking of the patient's condition and ensuring appropriate management strategies are implemented.
In SOAP notes, ICD-10 Code C82.58 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse follicle center lymphoma. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
Management of diffuse follicle center lymphoma requires a multidisciplinary approach, often necessitating hospitalization for treatment initiation.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.58 is critical in medical billing, particularly in hospital, emergency room, or oncology settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymphatic system, including lymphangiography. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C82.58 for Diffuse follicle center lymphoma, lymph nodes mult site
What are the common symptoms of diffuse follicle center lymphoma?
Common symptoms include painless swelling of lymph nodes, unexplained weight loss, fever, and night sweats. Patients may also experience fatigue and other systemic symptoms.
How is diffuse follicle center lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of malignant B-cells.
What treatments are available for diffuse follicle center lymphoma?
Treatment options may include chemotherapy, targeted therapy, and radiation therapy, depending on the stage and aggressiveness of the lymphoma.
Is diffuse follicle center lymphoma curable?
While some patients may achieve remission, diffuse follicle center lymphoma can be challenging to cure, and treatment often focuses on managing symptoms and prolonging survival.
Clinical Notes
SOAP notes
DAP notes
AI medical notes